Evidence map›Paper›PMID 29572288›Full record

ArticlePediatrics2018

Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004

Tyler N A Winkelman, Nicole Villapiano, Katy B Kozhimannil, Matthew M Davis, Stephen W Patrick

Registry-linked trialAbstract read
In one paragraph

Article in Pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06576323 (An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care), which is not on this map. Cited by 199 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
199citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06576323 narecruitingnot on this mapstarted 2024, after this paper: background citation

An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care

TypeinterventionalSponsorUniversity of PennsylvaniaRan2024 to 2027Enrolled50ConditionsOpioid Use Disorder, Neonatal Abstinence SyndromeArmsAn implementation model for co-located Medications for Opioid Use Disorder (MOUD) prescription in the NICU
3 · Its place in the literature

Who cites it

199 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Non-pharmacological care for opioid withdrawal in newborns.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article

139 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tyler N A WinkelmanDivision of General Internal Medicine, Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota; tyler.winkelman@hcmed.org.
Nicole VillapianoFamily Health Network, Cortland Regional Medical Center, Cortland, New York.
Katy B KozhimannilDivision of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Matthew M DavisMary Ann & J. Milburn Smith Child Health Research Program, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois.
Stephen W PatrickDepartments of Pediatrics and.

Funding

Neonatal Abstinence Syndrome: Risk of Drug Withdrawal in Opioid-Exposed InfantsK23DA038720 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PATRICK, STEPHEN W · 2015 to 2019
$844k
NIDA NIH HHS K23 DA038720
6 · The paper itself

Abstract

objectivesTo describe incidence, health care use, and cost trends for infants with neonatal abstinence syndrome (NAS) who are covered by Medicaid compared with other infants.

methodsWe used 2004-2014 hospital birth data from the National Inpatient Sample, a nationally representative sample of hospital discharges in the United States (

resultsMedicaid covered 73.7% of NAS-related births in 2004 (95% confidence interval [CI], 68.9%-77.9%) and 82.0% of NAS-related births in 2014 (95% CI, 80.5%-83.5%). Among infants covered by Medicaid, NAS incidence increased more than fivefold during our study period, from 2.8 per 1000 births (95% CI, 2.1-3.6) in 2004 to 14.4 per 1000 births (95% CI, 12.9-15.8) in 2014. Infants with NAS who were covered by Medicaid were significantly more likely to be transferred to another hospital and have a longer length of stay than infants without NAS who were enrolled in Medicaid or infants with NAS who were covered by private insurance. Adjusting for inflation, total hospital costs for NAS births that were covered by Medicaid increased from $65.4 million in 2004 to $462 million in 2014. The proportion of neonatal hospital costs due to NAS increased from 1.6% in 2004 to 6.7% in 2014 among births that were covered by Medicaid.

conclusionsThe number of Medicaid-financed births that are impacted by NAS has risen substantially and totaled $462 million in hospital costs in 2014. Improving affordable health insurance coverage for low-income women before pregnancy would expand access to substance use disorder treatment and could reduce NAS-related morbidity and costs.

Indexed as

Cross-Sectional StudiesFemaleHospital CostsHumansIncidenceInfant, NewbornMaleMedicaidNeonatal Abstinence SyndromeUnited States

Identifiers

PMID29572288
PMCPMC5869343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.